Searched for
DIVIS LABORATORIES SHARES
Sunil Singhania-backed Abakkus Flexi Cap Fund increases stake in HDFC Bank, RIL and 29 others in MaySunil Singhania-backed Abakkus Flexi Cap Fund significantly increased its holdings in HDFC Bank and Reliance Industries during May. The fun...- Sunil Singhania-backed Abakkus Small Cap Fund adds 3 new stocks, increases stake in HDFC Bank, SBI and 49 othersSunil Singhania's Abakkus Small Cap Fund added three new stocks in May, including Tanla Platforms and Intellect Design Arena. The fund also...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- More women CXOs join India’s million-dollar pay club as domestic firms lead compensation growthNine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announcedDivi's Laboratories Q4 Results: Divi's Laboratories announced strong financial results for the March quarter. Net profit rose 13% to Rs 751...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Divi's Lab inks supply pact with global pharmaceutical entityDivi's Laboratories announced a long-term supply agreement with a global pharmaceutical company, focusing on manufacturing and supplying ad...
- Divis Labs share price 1.75 per centA total of 7,630 shares changed hands on the counter till 02:04PM (IST).
- Divis Labs shares 2.26% as Sensex risesThe stock quoted a 52-week high of Rs 6448.75 and a 52-week low of Rs 3350.05.
- Share price of Divis Labs as Sensex drops 463.32 pointsA total of 2,405 shares changed hands on the counter till 01:49PM (IST)
- Buy Divi's Laboratories, target price Rs 3742: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 98115.86 Crore) operating in Pharmace...
- Divi's Labs shares drop 2% on brokerage downgrades post Q1 result. Should you buy, sell or hold?Divi's Laboratories on Monday saw a 49% year-on-year (YoY) fall in its consolidated net profit at Rs 356 crore for the quarter ended June 2...
- Buy Divi's Laboratories, target price Rs 3762: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 99034.38 Crore) operating in Pharmace...
- Divi's Labs Q1 Results: Profit nearly halves to Rs 356 crore on YoY basis, misses estimatesRevenue from operations during the first quarter dropped 21% to Rs 1,778 crore, compared with Rs 2,255 crore in the same quarter of last ye...
- Buy Divi's Laboratories, target price Rs 4130: Religare BrokingPromoters held 51.93 per cent stake in the company as of 30-Jun-2023, while FIIs owned 14.69 per cent, DIIs 21.03 per cent.
- Divi's Lab shares jump over 9% as exports rise in MarchThe consensus recommendation from 23 analysts for Divi's Lab is Sell. Out of these analysts, only six have strong buy and buy ratings, whil...
- Divi's Labs shares fall 9% post Sept quarter numbers; here's whyWe envisage near term pressures growin for Divi's Labs, with rising raw material prices, logistical issues and declining generics business,...
- India’s best-performing stock is seeing a wave of optimistic callsThe optimism is stemming from the company’s capacity-expansion plans and potential to win more business as India cuts its reliance on Chine...
- Buy Divi's Laboratories Ltd with a target of Rs 1520: Sandeep Wagle"Divi's Laboratories Ltd is a 'BUY' call with a target of Rs 1520 and a stop loss of Rs 1402."
Load More
